Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. (Q42627458)
Jump to navigation
Jump to search
scientific article published on May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. |
scientific article published on May 2004 |
Statements
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer (English)
Mark D Pegram
Donald W Northfelt
Wolfgang Eiermann
Ravi Patel
Pierre Fumoleau
Eleonor Quan
John Crown
Deborah Toppmeyer
Michael Smylie
Alessandro Riva
Sandra Blitz
Michael F Press
David Reese
Mary-Ann Lindsay
Dennis J Slamon
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference